marketcaparena
Search

    CURX

    Curanex Pharmaceuticals Inc

    Company overview

    Market capitalization
    $157.92M
    Employees
    —
    Latest publication
    2026-09-29
    About Curanex Pharmaceuticals Inc

    Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue0USD0USD0USD0USD0USD0USD0USD0USD
    Research Development2,256,162USD2,308,399USD677,474USD—0USD—0USD—
    Selling General Administrative927,197USD784,240USD273,853USD57,658USD137,452USD63,915USD102,070USD44,200USD
    Total Operating Expenses3,183,359USD3,092,639USD951,327USD57,658USD137,452USD138,591USD102,070USD44,200USD
    Operating Income-3,183,359USD-3,092,639USD-951,327USD-57,658USD-137,452USD-138,591USD-102,070USD-44,200USD
    Interest Expense0USD17,074USD4,090USD3,091USD1,356USD—0USD0USD
    Net Interest Income0USD0USD-4,090USD-3,091USD-1,356USD—0USD0USD
    Income Before Tax-3,150,228USD-3,073,118USD-954,059USD-60,346USD-137,583USD-137,163USD-99,942USD-44,200USD
    Net Income-3,150,228USD-3,073,118USD-954,059USD-60,346USD-137,583USD-137,163USD-99,942USD-44,200USD
    Net Income From Continuing Ops-3,150,228USD-3,073,118USD-954,059USD-60,346USD-137,583USD-137,163USD-99,942USD-44,200USD
    Ebitda-3,183,359USD-3,140,727USD-934,530USD-42,225USD-121,594USD-63,915USD-102,070USD-44,200USD
    Reconciled Depreciation35,041USD34,294USD15,439USD15,030USD14,633USD0USD0USD0USD
    Total Other Income Expense Net33,131USD19,521USD-2,732USD-2,688USD-131USD1,428USD2,128USD—
    Cost Of Revenue—-15,030USD—15,030USD————
    Gross Profit—15,030USD—-15,030USD————
    Ebit—-3,095,625USD-949,969USD-57,255USD-136,227USD———
    Depreciation And Amortization—-45,102USD15,439USD15,030USD14,633USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Revenue0USD0USD0USD26,000USD
    Research Development2,985,873USD0USD——
    Selling General Administrative1,253,203USD290,386USD19,298USD24,662USD
    Total Operating Expenses4,239,076USD365,062USD19,298USD24,662USD
    Operating Income-4,239,076USD-365,062USD-19,298USD-20,233USD
    Interest Expense8,537USD0USD——
    Net Interest Income-8,537USD0USD——
    Income Before Tax-4,225,106USD-361,506USD-19,198USD-20,233USD
    Net Income-4,225,106USD-361,506USD-19,198USD-20,233USD
    Net Income From Continuing Ops-4,225,106USD-361,506USD-19,198USD-20,233USD
    Ebitda-4,239,076USD-290,386USD-17,483USD925USD
    Reconciled Depreciation79,396USD0USD1,815USD21,158USD
    Total Other Income Expense Net13,970USD3,556USD100USD—
    Cost Of Revenue——0USD21,571USD
    Gross Profit——0USD4,429USD
    Ebit——-19,298USD-20,233USD
    Depreciation And Amortization——1,815USD21,158USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets5,073,932USD8,411,292USD11,580,124USD14,478,157USD787,174USD786,940USD517,935USD646,122USD
    Cash And Equivalents2,938,463USD———————
    Total Current Assets4,792,993USD8,093,718USD11,227,508USD14,417,759USD711,337USD696,072USD517,935USD571,447USD
    Total Liabilities286,254USD———————
    Total Current Liabilities104,306USD128,734USD137,030USD185,955USD75,927USD192,605USD14,575USD5,600USD
    Other Current Liabilities9,741USD———————
    Total Stockholder Equity4,787,678USD8,078,648USD11,219,084USD14,292,202USD305,431USD365,777USD503,360USD640,523USD
    Total Equity Including Noncontrolling Interest4,787,678USD———————
    Property Plant Equipment Net280,939USD317,574USD352,616USD60,398USD75,837USD90,868USD0USD—
    Accounts Payable154USD8,404USD2,426USD114,489USD269USD126,057USD5,000USD—
    Short Term Debt94,411USD107,090USD122,689USD61,150USD70,636USD62,618USD——
    Common Stock2,836USD2,836USD2,834USD2,834USD2,400USD2,400USD2,400USD4,000USD
    Retained Earnings-11,288,753USD-7,997,783USD-4,847,555USD-1,774,437USD-820,378USD-760,032USD-622,449USD-485,286USD
    Other Current Assets—4,075,144USD6,254,374USD8,587,222USD602,475USD497,129USD369,044USD327,127USD
    Total Liab—332,644USD361,040USD185,955USD481,743USD421,163USD14,575USD5,599USD
    Other Current Liab—13,240USD11,915USD10,316USD5,022USD3,905USD9,550USD4,000USD
    Capital Stock—2,936USD2,934USD2,934USD2,500USD2,500USD2,500USD4,100USD
    Cash—4,018,574USD4,973,134USD5,830,537USD108,862USD198,943USD148,891USD244,320USD
    Cash And Short Term Investments—4,018,574USD4,973,134USD5,830,537USD108,862USD198,943USD148,891USD244,320USD
    Net Debt—-3,707,574USD-4,626,435USD-5,769,387USD367,590USD92,233USD-148,891USD-244,320USD
    Short Long Term Debt Total—311,000USD346,699USD61,150USD476,452USD291,176USD——
    Property Plant Equipment Gross—317,574USD352,616USD60,398USD75,837USD90,868USD0USD—
    Common Stock Shares Outstanding—28,344,545shares25,497,328shares25,599,673shares27,750,000shares27,750,000shares27,750,000shares27,750,000shares
    Non Current Assets Total—317,574USD352,616USD60,398USD75,837USD90,868USD0USD74,676USD
    Non Current Liabilities Total—203,910USD224,010USD0USD405,816USD228,558USD0USD-1USD
    Net Working Capital—7,964,984USD11,090,478USD14,231,804USD635,410USD503,467USD503,360USD565,847USD
    Unclassified Equity—16,070,659USD16,060,871USD16,060,871USD1,120,909USD1,120,909USD1,120,909USD1,117,709USD
    Long Term Debt————400,000USD200,000USD——
    Intangible Assets———————74,676USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Total Assets11,580,124USD517,935USD74,366USD10,232USD
    Other Current Assets6,254,374USD369,044USD—1,815USD
    Total Liab361,040USD14,575USD14,276USD0USD
    Total Stockholder Equity11,219,084USD503,360USD60,090USD10,232USD
    Other Current Liab11,915USD9,550USD13,676USD—
    Common Stock2,834USD2,400USD60USD—
    Capital Stock2,934USD2,500USD60USD100USD
    Retained Earnings-4,847,555USD-622,449USD-260,943USD-241,745USD
    Cash4,973,134USD148,891USD74,366USD2,430USD
    Cash And Short Term Investments4,973,134USD148,891USD74,366USD—
    Total Current Assets11,227,508USD517,935USD74,366USD10,232USD
    Total Current Liabilities137,030USD14,575USD14,276USD0USD
    Net Debt-4,626,435USD-148,891USD-74,366USD—
    Short Term Debt122,689USD———
    Short Long Term Debt Total346,699USD———
    Accounts Payable2,426USD5,000USD0USD—
    Property Plant Equipment Net352,616USD0USD——
    Property Plant Equipment Gross352,616USD0USD——
    Common Stock Shares Outstanding25,497,328shares27,750,000shares42,000,000shares42,000,000shares
    Non Current Assets Total352,616USD0USD0USD0USD
    Non Current Liabilities Total224,010USD0USD0USD0USD
    Net Working Capital11,090,478USD503,360USD60,090USD10,232USD
    Unclassified Equity16,060,871USD1,120,909USD——
    Inventory——0USD2,987USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation9,792USD
    Change To Liabilities-4,446USD
    Change In Working Capital-2,272USD
    Operating Cash Flow-2,034,671USD
    Change In Cash-2,034,671USD
    End Cash Flow2,938,463USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-3,150,228USD-3,073,118USD-954,059USD-60,346USD-137,583USD-137,163USD-91,166USD-44,200USD
    Depreciation35,041USD34,294USD15,439USD15,030USD14,633USD0USD0USD0USD
    Stock Based Compensation9,792USD———0USD———
    Other Non Cash Items2,150,835USD2,181,420USD-8,520,162USD—————
    Change In Working Capital2,150,835USD2,181,420USD271,763USD-244,765USD-26,998USD-32,942USD-38,777USD-192,128USD
    Total Cash From Operating Activities-954,560USD-857,404USD-9,187,019USD-290,081USD-149,948USD-95,429USD-129,943USD-236,328USD
    Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
    Free Cash Flow-954,560USD-857,404USD-9,187,019USD-290,081USD-149,948USD-95,429USD-129,943USD-236,330USD
    Net Borrowings0USD——200,000USD200,000USD———
    Total Cash From Financing Activities0USD0USD14,908,695USD200,000USD200,000USD0USD0USD580,100USD
    Change In Cash-954,560USD-857,403USD5,721,675USD-90,081USD50,052USD-95,429USD-129,944USD374,261USD
    Begin Period Cash Flow4,973,134USD5,830,537USD108,862USD198,943USD148,891USD244,320USD374,261USD30,489USD
    End Period Cash Flow4,018,574USD4,973,134USD5,830,537USD108,862USD198,943USD148,891USD244,317USD374,261USD
    Unclassified Operating Cash Flow-2,150,835USD-2,181,420USD——————
    Issuance Of Capital Stock—0USD15,655,192USD0USD0USD0USD0USD580,100USD
    Other Cashflows From Financing Activities—400,000USD14,908,695USD————-50,000USD
    Unclassified Financing Cash Flow——-15,655,192USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USD
    Net Income-4,225,106USD-361,506USD-19,198USD-20,233USD
    Depreciation79,396USD0USD1,815USD21,158USD
    Other Non Cash Items-6,338,742USD74,676USD——
    Change In Working Capital-6,338,742USD-268,745USD17,263USD2,411USD
    Total Cash From Operating Activities-10,484,452USD-555,575USD-120USD3,336USD
    Capital Expenditures0USD-5USD0USD0USD
    Free Cash Flow-10,484,452USD-555,575USD-120USD3,336USD
    Total Cash From Financing Activities15,308,695USD630,100USD72,056USD-3,000USD
    Issuance Of Capital Stock15,655,192USD630,100USD69,056USD0USD
    Change In Cash4,824,243USD74,525USD71,936USD336USD
    Begin Period Cash Flow148,891USD74,366USD2,430USD2,094USD
    End Period Cash Flow4,973,134USD148,891USD74,366USD2,430USD
    Other Cashflows From Financing Activities15,308,695USD100USD3,000USD—
    Unclassified Operating Cash Flow6,338,742USD———
    Unclassified Financing Cash Flow-15,655,192USD———
    Change To Inventory—0USD2,987USD21,571USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.